Anti-CD37 antibodies for chronic lymphocytic leukemia

By Robak Tadeusz   Robak Pawel  

Expert Opinion on Biological Therapy, Vol. 14, Iss. 5, 2014-05 ,pp. : 651-661

Informa Healthcare

Access to resources Recommend Favorite

MicroRNAs as Main Players in the Pathogenesis of Chronic Lymphocytic Leukemia

By  

MicroRNA, Vol. 2, Iss. 3, 2013-11 ,pp. : 158-164

Bentham Science Publishers

Access to resources Recommend Favorite

Chemokine-dependent B cell–T cell interactions in chronic lymphocytic leukemia and multiple myeloma – targets for therapeutic intervention?

By Jöhrer Karin   Hofbauer Sebastian W   Zelle-Rieser Claudia   Greil Richard   Hartmann Tanja N  

Expert Opinion on Biological Therapy, Vol. 12, Iss. 4, 2012-04 ,pp. : 425-441

Informa Healthcare

Access to resources Recommend Favorite

Imbalanced Expression of the Glucocorticoid Receptor Isoforms in Cultured Lymphocytes from a Patient with Systemic Glucocorticoid Resistance and Chronic Lymphocytic Leukemia

By Shahidi H.   Vottero A.   Stratakis C.A.   Taymans S.E.   Karl M.   Longui C.A.   Chrousos G.P.   Daughaday W.H.   Gregory S.A.   Plate J.M.D.  

Biochemical and Biophysical Research Communications, Vol. 254, Iss. 3, 1999-01 ,pp. : 559-565

Elsevier

Access to resources Recommend Favorite

Sex differences in the incidence of chronic myeloid leukemia

By Radivoyevitch Tomas   Jankovic Gradimir   Tiu Ramon   Saunthararajah Yogen   Jackson Robert   Hlatky Lynn   Gale Robert   Sachs Rainer  

Radiation and Environmental Biophysics, Vol. 53, Iss. 1, 2014-03 ,pp. : 55-63

Springer Publishing Company

Access to resources Recommend Favorite